{ "items": [ "\n\n
\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Public engagement\n \n \n\n \n\n\n
\n \n\n \n24 March 2017
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Event\n \n \n \n \n Integrative Neuroimaging\n \n \n\n \n\n\n
\n \n\n \n21 March 2017
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n\n \n\n\n
\n \n\n \n20 March 2017
\n \n \n \nResearchers have started a new gene therapy clinical trial to treat X-linked retinitis pigmentosa (XLRP), the most common cause of blindness in young people.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n17 March 2017
\n \n \n \nOxford University and Kingsley Capital Partners have launched a new research programme to investigate the role of cannabinoids in biology and medicine.
\n \n\n \n \n\n \n\n \n \n \n \n Integrative Neuroimaging\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n16 February 2017
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Integrative Neuroimaging\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n16 February 2017
\n \n \n \nStroke remains the biggest cause of disability in the UK, and completely changed the life of celebrated broadcaster and political journalist Andrew Marr in 2013. The life-threatening stroke resulted in his family being told twice that he was unlikely to survive, and if he did, that he may never regain normal speech, cognitive function or movement.
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Integrative Neuroimaging\n \n \n\n \n\n\n
\n \n\n \n30 January 2017
\n \n \n \nTwo Troland Research Awards are given annually to recognise unusual achievement by young investigators and to further research within the broad spectrum of experimental psychology.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n13 January 2017
\n \n \n \nProfessor Andrea N\u00e9meth has successfully applied to the John Fell Fund to establish the Oxford Neurodevelopment Consortium (OxNDC).
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n\n \n\n\n
\n \n\n \n9 January 2017
\n \n \n \nThe purpose of the Feldberg Foundation is the promotion of scientific contact between German and English scientists within the sphere of experimental medical research.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n SCNi\n \n \n\n \n\n\n
\n \n\n \n3 January 2017
\n \n \n \nCircadian Therapeutics has been established to identify and bring to market pharmaceutical and diagnostic platforms for the effective management of physiological and pathological conditions through their ability to modify the body's circadian rhythms.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n12 December 2016
\n \n \n \nOur researchers have been granted 600K euros from EU\u2019s Horizon 2020 Framework Programme to join in a multi-centre initiative studying a new drug for Parkinson's disease
\n \n\n \n \n\n \n\n \n \n \n \n Integrative Neuroimaging\n \n \n\n \n\n\n
\n \n\n \n7 December 2016
\n \n \n \nThe Wellcome Trust has today announced five-year funding for 14 major research centres, including a centre for neuroimaging in Oxford
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n24 November 2016
\n \n \n \nA clear link between the activity in nerve clusters in the brain and the amount of force generated in a physical action has been demonstrated by our researchers, opening the way for the development of better devices to assist paralysed patients.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n10 November 2016
\n \n \n \nThe trial involves injecting a virus into the eye to deliver billions of healthy genes to replace a key missing gene for choroideremia sufferers.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n3 November 2016
\n \n \n \nNew research from our Department has raised the possibility of minimising the side effects of treatment for patients with autoimmune diseases, such as multiple sclerosis and inflammatory bowel disease.
\n \n\n \n \n\n \n\n \n \n \n \n Anaesthetics\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n31 October 2016
\n \n \n \nThe SILENCE project, funded by the NIHR Research for Patient Benefit stream, featured on BBC Radio 4 Inside Health on 4 October 2016.
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Clinical Neurology\n \n \n\n \n\n\n
\n \n\n \n25 October 2016
\n \n \n \nSix universities including Oxford have been awarded a total of \u00a34.3m by the Medical Research Council (MRC) to grow and develop the UK\u2019s research base in dementia science.
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Clinical Neurology\n \n \n\n \n\n\n
\n \n\n \n19 October 2016
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n\n \n\n\n
\n \n\n \n19 October 2016
\n \n \n \n\n \n \n17 October 2016
\n \n \n \nProfessor Chris Kennard retired at the end of September 2016
\n \n\n \n \n